Back to search
FDAFDA · Food and drugs·Recall number D-1314-2014

Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4581-11

Published May 14, 2014 · Recall initiated: April 4, 2014

Summary

FDA records drug Class III recall D-1314-2014, published May 14, 2014 and initiated April 4, 2014. Recalling firm: Boehringer Ingelheim Roxane Inc; Status: Terminated; Reported quantity: 98,560 bottles; Lot: Lot 261997A Exp 02/16; 262214V, 359283V Exp. 05/16. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.

What to do

Voluntary: Firm initiated · Letter

Get an email if MERCAPTOPURINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MERCAPTOPURINE
Manufacturer
Boehringer Ingelheim Roxane Inc
Distributor
Nationwide
UPC
0300544581271
Lot
Lot 261997A Exp 02/16; 262214V, 359283V Exp. 05/16
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4581-11 recalled?

Yes. FDA published recall D-1314-2014 on May 14, 2014. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MERCAPTOPURINE. UPC: 0300544581271.